Reaction
Instillation Site Erythema reporting signals
As of the last recalculation, Instillation Site Erythema appears in 525 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is LIFITEGRAST (PRR 848.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Lifitegrast | 210 | 848.6 | 859.7 |
| Carboxymethylcellulose Sodium | 10 | 43.0 | 43.0 |
| Dorzolamide Hydrochloride And Timolol Maleate | 8 | 40.7 | 40.8 |
| Brimonidine Tartrate | 17 | 39.1 | 39.1 |
| Timolol Maleate | 6 | 24.3 | 24.3 |
| Latanoprost | 26 | 21.5 | 21.5 |
| Travoprost | 4 | 18.5 | 18.5 |